Video

How Can We Improve LNP Formulation For Therapeutic Applications?

Source: Advancing RNA

Life Edit Therapeutics’ April Sena and Tune Therapeutics’ Tyler Goodwin delve into where they see limitations in downstream processing technologies impacting our ability to scale-up high-quality mRNA-LNPs for large scale therapeutics.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)